Correlation Between Polydex Pharmaceuticals and OncoVista Innovative
Can any of the company-specific risk be diversified away by investing in both Polydex Pharmaceuticals and OncoVista Innovative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Polydex Pharmaceuticals and OncoVista Innovative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Polydex Pharmaceuticals and OncoVista Innovative Therapies, you can compare the effects of market volatilities on Polydex Pharmaceuticals and OncoVista Innovative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Polydex Pharmaceuticals with a short position of OncoVista Innovative. Check out your portfolio center. Please also check ongoing floating volatility patterns of Polydex Pharmaceuticals and OncoVista Innovative.
Diversification Opportunities for Polydex Pharmaceuticals and OncoVista Innovative
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Polydex and OncoVista is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Polydex Pharmaceuticals and OncoVista Innovative Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoVista Innovative and Polydex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Polydex Pharmaceuticals are associated (or correlated) with OncoVista Innovative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoVista Innovative has no effect on the direction of Polydex Pharmaceuticals i.e., Polydex Pharmaceuticals and OncoVista Innovative go up and down completely randomly.
Pair Corralation between Polydex Pharmaceuticals and OncoVista Innovative
Assuming the 90 days horizon Polydex Pharmaceuticals is expected to generate 2.34 times more return on investment than OncoVista Innovative. However, Polydex Pharmaceuticals is 2.34 times more volatile than OncoVista Innovative Therapies. It trades about 0.09 of its potential returns per unit of risk. OncoVista Innovative Therapies is currently generating about 0.05 per unit of risk. If you would invest 65.00 in Polydex Pharmaceuticals on November 2, 2024 and sell it today you would earn a total of 131.00 from holding Polydex Pharmaceuticals or generate 201.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.54% |
| Values | Daily Returns |
Polydex Pharmaceuticals vs. OncoVista Innovative Therapies
Performance |
| Timeline |
| Polydex Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| OncoVista Innovative |
Polydex Pharmaceuticals and OncoVista Innovative Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Polydex Pharmaceuticals and OncoVista Innovative
The main advantage of trading using opposite Polydex Pharmaceuticals and OncoVista Innovative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Polydex Pharmaceuticals position performs unexpectedly, OncoVista Innovative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoVista Innovative will offset losses from the drop in OncoVista Innovative's long position.| Polydex Pharmaceuticals vs. ImmuCell | Polydex Pharmaceuticals vs. Senstar Technologies | Polydex Pharmaceuticals vs. Natural Alternatives International | Polydex Pharmaceuticals vs. Paragon Technologies |
| OncoVista Innovative vs. Cyclacel Pharmaceuticals | OncoVista Innovative vs. Amylyx Pharmaceuticals | OncoVista Innovative vs. Axsome Therapeutics | OncoVista Innovative vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |